Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Atossa Therapeutics Inc ATOS

Healthcare Biotechnology
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to prevent and treat breast cancer. Its lead drug candidate under development is oral (Z)-endoxifen, which it is developing for both the prevention and treatment of breast cancer. (Z)-endoxifen... see more

Recent & Breaking News (NDAQ:ATOS)

Five Star Equities Issues New Research Reports on ATOS, BDSI, PTCT and TNXP

Accesswire January 28, 2014

Real Good Solar Takes On New Name, Ticker Symbol and Strategy: Real Goods Solar Inc. (NASDAQ:RSOL), Atossa Genetics Inc. (NASDAQ: ATOS), Chelsea Therapeutics International, Ltd. (NASDAQ:CHTP)

Accesswire January 28, 2014

Atossa Genetics Inc. Announces Pricing of a Public Offering of Common Stock and Warrants

Marketwired January 24, 2014

Atossa Genetics Inc. Announces Proposed Public Offering of Common Stock and Warrants

Marketwired January 23, 2014

Atossa Genetics to Present at Two Upcoming Investor Conferences

Marketwired January 9, 2014

Atossa Genetics Submits Premarket 510(k) Notification for ForeCYTE Breast Aspirator

Marketwired December 24, 2013

Atossa Genetics Announces Two Scientific Presentations at the 2013 San Antonio Breast Cancer Symposium

Marketwired December 3, 2013

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Atossa Genetics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ATOS

Globe Newswire December 2, 2013

EQUITY ALERT: Rosen Law Firm Reminds Atossa Genetics, Inc. Investors of Important Class Action Deadline -- ATOS

Globe Newswire November 27, 2013

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Atossa Genetics, Inc. of Upcoming Deadline

Business Wire November 25, 2013

UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against Atossa Genetics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ATOS

Business Wire November 22, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm has filed a Class Action Against Atossa Genetics, Inc. and Certain Officers - ATOS

PR Newswire November 22, 2013

Five Star Equities Issues New Research Reports on ACFN, ATOS, MACK and NSYS

Accesswire November 19, 2013

TrendingWallStreet.com Begins Analysis on DANG, NENE, NVGC, and ATOS

Accesswire November 19, 2013

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Atossa Genetics, Inc. to Contact the Firm

Marketwired November 15, 2013

Atossa Genetics Reports Third Quarter 2013 Results and Provides Company Update

Marketwired November 12, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Has Filed a Class Action Against Atossa Genetics, Inc. and Certain Officers -- ATOS

Marketwired November 8, 2013

Atossa Genetics to Announce Third Quarter 2013 Results on Tuesday, November 12, 2013

Marketwired November 8, 2013

ATOSSA GENETICS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Class Action Against Atossa Genetics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ATOS

Marketwired October 29, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Atossa Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline -- ATOS

Globe Newswire October 25, 2013